Saeyan Choi1, Bokyeong Song1, Hyewon Shin1, Chihyun Won1, Taejoon Kim1, Hideki Yoshida2, Daewon Lee3, Jongkyeong Chung3, Kyoung Sang Cho1, Im-Soon Lee4. 1. Department of Biological Sciences, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea. 2. Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan. 3. School of Biological Sciences, Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea. 4. Department of Biological Sciences, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea. islee@konkuk.ac.kr.
Abstract
BACKGROUND: Haploinsufficiency of the human nuclear receptor binding suppressor of variegation 3-9, enhancer of zeste, and trithorax (SET) domain 1 (NSD1) gene causes a developmental disorder called Sotos syndrome 1 (SOTOS1), which is associated with overgrowth and macrocephaly. NSD family proteins encoding histone H3 lysine 36 (H3K36) methyltransferases are conserved in many species, and Drosophila has a single NSD homolog gene, NSD. OBJECTIVE: To gain insight into the biological functions of NSD1 deficiency in the developmental anomalies seen in SOTOS1 patients using an NSD-deleted Drosophila mutant. METHODS: We deleted Drosophila NSD using CRISPR/Cas9-mediated targeted gene knock-out, and analyzed pleiotropic phenotypes of the homozygous mutant of NSD (NSD-/-) at various developmental stages to understand the roles of NSD in Drosophila. RESULTS: The site-specific NSD deletion was confirmed in the mutant. The H3K36 di-methylation levels were dramatically decreased in the NSD-/- fly. Compared with the control, the NSD-/- fly displayed an increase in the body size of larvae, similar to the childhood overgrowth phenotype of SOTOS1 patients. Although the NSD mutant flies survived to adulthood, their fecundity was dramatically decreased. Furthermore, the NSD-/- fly showed neurological dysfunctions, such as lower memory performance and motor defects, and a diminished extracellular signal-regulated kinase (ERK) activity. CONCLUSIONS: The NSD-deleted Drosophila phenotype resembles many of the phenotypes of SOTOS1 patients, such as learning disability, deregulated ERK signaling, and overgrowth; thus, this mutant fly is a relevant model organism to study various SOTOS1 phenotypes.
BACKGROUND: Haploinsufficiency of the human nuclear receptor binding suppressor of variegation 3-9, enhancer of zeste, and trithorax (SET) domain 1 (NSD1) gene causes a developmental disorder called Sotos syndrome 1 (SOTOS1), which is associated with overgrowth and macrocephaly. NSD family proteins encoding histone H3 lysine 36 (H3K36) methyltransferases are conserved in many species, and Drosophila has a single NSD homolog gene, NSD. OBJECTIVE: To gain insight into the biological functions of NSD1 deficiency in the developmental anomalies seen in SOTOS1 patients using an NSD-deleted Drosophila mutant. METHODS: We deleted Drosophila NSD using CRISPR/Cas9-mediated targeted gene knock-out, and analyzed pleiotropic phenotypes of the homozygous mutant of NSD (NSD-/-) at various developmental stages to understand the roles of NSD in Drosophila. RESULTS: The site-specific NSD deletion was confirmed in the mutant. The H3K36 di-methylation levels were dramatically decreased in the NSD-/- fly. Compared with the control, the NSD-/- fly displayed an increase in the body size of larvae, similar to the childhood overgrowth phenotype of SOTOS1 patients. Although the NSD mutant flies survived to adulthood, their fecundity was dramatically decreased. Furthermore, the NSD-/- fly showed neurological dysfunctions, such as lower memory performance and motor defects, and a diminished extracellular signal-regulated kinase (ERK) activity. CONCLUSIONS: The NSD-deleted Drosophila phenotype resembles many of the phenotypes of SOTOS1 patients, such as learning disability, deregulated ERK signaling, and overgrowth; thus, this mutant fly is a relevant model organism to study various SOTOS1 phenotypes.
Authors: Jenny Douglas; Sandra Hanks; I Karen Temple; Sally Davies; Alexandra Murray; Meena Upadhyaya; Susan Tomkins; Helen E Hughes; Trevor R P Cole; Nazneen Rahman Journal: Am J Hum Genet Date: 2002-12-02 Impact factor: 11.025
Authors: Matthew R Fickie; Pablo Lapunzina; Jennifer K Gentile; Nina Tolkoff-Rubin; Daniela Kroshinsky; Enrique Galan; Esther Gean; Loreto Martorell; Valeria Romanelli; Joaquín Fernandez Toral; Angela E Lin Journal: Am J Med Genet A Date: 2011-08-10 Impact factor: 2.802
Authors: Laurel B Bender; Jinkyo Suh; Coleen R Carroll; Youyi Fong; Ian M Fingerman; Scott D Briggs; Ru Cao; Yi Zhang; Valerie Reinke; Susan Strome Journal: Development Date: 2006-10 Impact factor: 6.868
Authors: Oliver Bell; Christiane Wirbelauer; Marc Hild; Annette N D Scharf; Michaela Schwaiger; David M MacAlpine; Frédéric Zilbermann; Fred van Leeuwen; Stephen P Bell; Axel Imhof; Dan Garza; Antoine H F M Peters; Dirk Schübeler Journal: EMBO J Date: 2007-11-15 Impact factor: 11.598
Authors: Nicola Dikow; Bianca Maas; Harald Gaspar; Martina Kreiss-Nachtsheim; Hartmut Engels; Alma Kuechler; Lutz Garbes; Christian Netzer; Teresa M Neuhann; Udo Koehler; Kristina Casteels; Koen Devriendt; Johannes W G Janssen; Anna Jauch; Katrin Hinderhofer; Ute Moog Journal: Am J Med Genet A Date: 2013-08-02 Impact factor: 2.802
Authors: Daphne S Cabianca; Celia Muñoz-Jiménez; Véronique Kalck; Dimos Gaidatzis; Jan Padeken; Andrew Seeber; Peter Askjaer; Susan M Gasser Journal: Nature Date: 2019-05-22 Impact factor: 49.962